Close

Exelixis (EXEL) Announces Statistically Significant Data from Cabozantinib Phase 2 in RCC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. CSX
5. UAL
6. EFX
7. ORCL
8. TSLA
9. CCI
10. INFY


Go back to Exelixis (EXEL) Announces Statistically Significant Data from Cabozantinib Phase 2 in RCC
Exelixis, Inc. (NASDAQ: EXEL) Delayed: 22.85 -0.02 (0.09%)
Previous Close $22.87    52 Week High $17.00 
Open $23.00    52 Week Low $3.55 
Day High $23.23    P/E N/A 
Day Low $22.84    EPS $-1.33 
Volume 685,357